Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma.

Huang M, Wu R, Chen L, Peng Q, Li S, Zhang Y, Zhou L, Duan L.

Front Immunol. 2019 Sep 18;10:2243. doi: 10.3389/fimmu.2019.02243. eCollection 2019.

2.

Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.

Wang Y, Yin K, Tian J, Xia X, Ma J, Tang X, Xu H, Wang S.

Adv Sci (Weinh). 2019 Jul 22;6(18):1901278. doi: 10.1002/advs.201901278. eCollection 2019 Sep 18.

3.

Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.

Song J, Lee J, Kim J, Jo S, Kim YJ, Baek JE, Kwon ES, Lee KP, Yang S, Kwon KS, Kim DU, Kang TH, Park YY, Chang S, Cho HJ, Kim SC, Koh SS, Kim S.

Oncotarget. 2016 Aug 9;7(32):51840-51853. doi: 10.18632/oncotarget.10123.

4.

S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.

Duan L, Wu R, Ye L, Wang H, Yang X, Zhang Y, Chen X, Zuo G, Zhang Y, Weng Y, Luo J, Tang M, Shi Q, He T, Zhou L.

PLoS One. 2013 Apr 26;8(4):e62092. doi: 10.1371/journal.pone.0062092. Print 2013. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/61e0cb2d-6d8c-41d7-99f2-d1b97581e207.

5.

IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.

Yang Q, Li X, Chen H, Cao Y, Xiao Q, He Y, Wei J, Zhou J.

Oncogene. 2017 May 25;36(21):2969-2980. doi: 10.1038/onc.2016.448. Epub 2017 Jan 16.

PMID:
28092673
6.

S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.

Wu R, Duan L, Cui F, Cao J, Xiang Y, Tang Y, Zhou L.

Exp Cell Res. 2015 Jun 10;334(2):228-38. doi: 10.1016/j.yexcr.2015.04.008. Epub 2015 Apr 20.

PMID:
25907296
7.

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.

OuYang LY, Wu XJ, Ye SB, Zhang RX, Li ZL, Liao W, Pan ZZ, Zheng LM, Zhang XS, Wang Z, Li Q, Ma G, Li J.

J Transl Med. 2015 Feb 1;13:47. doi: 10.1186/s12967-015-0410-7.

8.

S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB.

Feng PH, Yu CT, Chen KY, Luo CS, Wu SM, Liu CY, Kuo LW, Chan YF, Chen TT, Chang CC, Lee CN, Chuang HC, Lin CF, Han CL, Lee WH, Lee KY.

Oncotarget. 2018 Jan 10;9(7):7631-7643. doi: 10.18632/oncotarget.24146. eCollection 2018 Jan 26. Erratum in: Oncotarget. 2018 Jul 31;9(59):31559.

10.

The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.

Lin Q, Ren L, Jian M, Xu P, Li J, Zheng P, Feng Q, Yang L, Ji M, Wei Y, Xu J.

Cell Death Dis. 2019 Sep 18;10(10):693. doi: 10.1038/s41419-019-1922-5.

11.

Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis.

Wu T, Wang C, Wang W, Hui Y, Zhang R, Qiao L, Dai Y.

Oncoimmunology. 2018 Aug 24;7(11):e1498437. doi: 10.1080/2162402X.2018.1498437. eCollection 2018.

12.

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.

Sun HL, Zhou X, Xue YF, Wang K, Shen YF, Mao JJ, Guo HF, Miao ZN.

World J Gastroenterol. 2012 Jul 7;18(25):3303-9. doi: 10.3748/wjg.v18.i25.3303.

13.
14.

Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of Helicobacter hepaticus-Induced Colitis.

De Cicco P, Sanders T, Cirino G, Maloy KJ, Ianaro A.

Front Immunol. 2018 Mar 27;9:499. doi: 10.3389/fimmu.2018.00499. eCollection 2018.

15.

[Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].

Pilatova K, Budinská E, Bensciková B, Nenutil R, Šefr R, Fedorová L, Hanáková B, Brychtová V, Zdražilová Dubská L.

Klin Onkol. Spring 2017;30(Supplementum1):166-169. Czech.

PMID:
28471197
16.

[The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis].

Tachibana M.

Yakugaku Zasshi. 2018;138(2):143-148. doi: 10.1248/yakushi.17-00158. Review. Japanese.

17.

S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells.

Gao H, Zhang X, Zheng Y, Peng L, Hou J, Meng H.

Mol Immunol. 2015 Oct;67(2 Pt B):223-32. doi: 10.1016/j.molimm.2015.05.014. Epub 2015 May 31.

PMID:
26038301
18.

Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.

Xiao P, Wan X, Cui B, Liu Y, Qiu C, Rong J, Zheng M, Song Y, Chen L, He J, Tan Q, Wang X, Shao X, Liu Y, Cao X, Wang Q.

Oncoimmunology. 2015 Jun 24;5(1):e1063772. eCollection 2016.

19.

Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer.

Jiang M, Chen J, Zhang W, Zhang R, Ye Y, Liu P, Yu W, Wei F, Ren X, Yu J.

Front Immunol. 2017 Dec 15;8:1840. doi: 10.3389/fimmu.2017.01840. eCollection 2017.

20.

CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.

Zhang H, Ye YL, Li MX, Ye SB, Huang WR, Cai TT, He J, Peng JY, Duan TH, Cui J, Zhang XS, Zhou FJ, Wang RF, Li J.

Oncogene. 2017 Apr;36(15):2095-2104. doi: 10.1038/onc.2016.367. Epub 2016 Oct 10.

PMID:
27721403

Supplemental Content

Support Center